Clinical trial

Dose-Escalating Multiple Dose Study of PD-0360324 in Combination With Methotrexate in Patients With Rheumatoid Arthritis

NCT00550355

Study summary

ClinicalTrials.gov

Dose-Escalating Multiple Dose Study of PD-0360324 in Combination With Methotrexate in Patients With Rheumatoid Arthritis

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention PD 0360324 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-08-01

PhasePHASE1

Conditions

Arthritis, Rheumatoidunresolved

Interventions

PD 0360324DRUG

PlaceboDRUG

Sponsors & collaborators

Pfizerlead sponsor

Mapped research locations

KrakowPoland2 SofiaBulgaria2 BialystokPoland2 Overland ParkKansas, United States2 DallasTexas, United States1 WarsawPoland1 PragueCzechia1 Buenos AiresArgentina1 WroclawPoland1 BrnoCzechia1 LansingMichigan, United States1 Mexico CityMexico City, Mexico1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00550355 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.